Overview
- TCS and AMD will co-develop industry-specific AI and generative AI solutions by pairing TCS’s domain and integration capabilities with AMD’s high‑performance compute portfolio.
- Initial focus areas include life sciences for drug discovery, manufacturing for cognitive quality engineering and smart factories, and BFSI for intelligent risk management.
- TCS will integrate AMD Ryzen for client solutions and deploy EPYC CPUs, Instinct GPUs, and AI accelerators in hybrid cloud and HPC, with embedded SoCs and FPGAs targeting edge inference and industrial digitalization.
- The companies plan to deliver tailored accelerators, frameworks, and best practices to improve performance across AI training and inference workloads.
- TCS will upskill and certify its workforce through new centres of excellence, building deployment capacity as it reports rising AI services revenue and positions the alliance as an alternative to hyperscaler-led stacks.